Spots Global Cancer Trial Database for Phase I and Pharmacokinetic Study of Mitoxantrone Hydrochloride Liposome Injection
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Phase I and Pharmacokinetic Study of Mitoxantrone Hydrochloride Liposome Injection
Official Title: Phase I and Pharmacokinetic Study of Mitoxantrone Hydrochloride Liposome Injection in Patients With Solid Tumor
Study ID: NCT02043756
Conditions
Study Description
Brief Summary: The purpose of the study is to examine the toxicity profile, maximum tolerated dose (MTD), and pharmacokinetics of Mitoxantrone Hydrochloride Liposome Injection.
Detailed Description: The trial of the dose escalation method is from the minimum dose until the maximum tolerated dose and every 3 patient is a dose group.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Contact Details
Name: Yuankai Shi, Ph.D
Affiliation: Cancer Hospital ,Chinese Academy of Mddical Sciences 010-87788701
Role: PRINCIPAL_INVESTIGATOR
Name: Jianliang Yang, Ph.D
Affiliation: Cancer Hospital ,Chinese Academy of Mddical Sciences 010-87788121
Role: STUDY_DIRECTOR
Name: Xiaohong Han, Ph.D
Affiliation: Cancer Hospital ,Chinese Academy of Mddical Sciences 010-87788701
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
